Radium-223 In The Treatment Of Metastatic Castration-Resistant Prostate Cancer

被引：0
|
作者：
Vazzana, C. [1 ]
Morano, S. [2 ]
Di Lascio, A. [3 ]
Grana, C. [4 ]
Chinol, M. [4 ]
机构：
[1] Veneto Oncol Inst IOV IRCCS, Padua, Italy
[2] Hosp Bianchi Melacrino Morelli, Reggio Di Calabria, Italy
[3] Hosp A Cardarelli, Naples, Italy
[4] European Inst Oncol, Milan, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
E-TPW39
引用
收藏
页码：S880 / S880
页数：1
相关论文
共 50 条
  • [21] Evolving treatment approaches for the management of metastatic castration-resistant prostate cancer - role of radium-223
    Mukherji, Deborah
    El Dika, Imane
    Temraz, Sally
    Haidar, Mohammed
    Shamseddine, Ali
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 373 - 380
  • [22] Radium-223 Dichloride in Peritoneal Dialysate Following Treatment of Metastatic Castration-resistant Prostate Cancer
    Saganich, Christopher
    Zgaljardic, Michael
    HEALTH PHYSICS, 2022, 122 (03): : 433 - 439
  • [23] Acute Promyelocytic Leukemia After Treatment of Metastatic Castration-Resistant Prostate Cancer With Radium-223
    Odo, Ugochukwu
    Vasudevamurthy, Ashwin K.
    Sartor, Oliver
    CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : E501 - E502
  • [24] Treatment intensification with radium-223 plus enzalutamide in patients with metastatic castration-resistant prostate cancer
    Shore, Neal
    Carles, Joan
    McDermott, Ray
    Agarwal, Neeraj
    Tombal, Bertrand
    FRONTIERS IN MEDICINE, 2024, 11
  • [25] Impact of treatment delay in Radium-223 therapy of metastatic castration-resistant prostate cancer patients
    Fosbol, Marie Obro
    Petersen, Peter Meidahl
    Daugaard, Gedske
    Holm, Soren
    Kjaer, Andreas
    Mortensen, Jann
    ANNALS OF NUCLEAR MEDICINE, 2018, 32 (01) : 16 - 21
  • [26] Factors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer
    Wong, William W.
    Anderson, Eric M.
    Mohammadi, Homan
    Daniels, Thomas B.
    Schild, Steve E.
    Keole, Sameer R.
    Choo, C. Richard
    Tzou, Katherine S.
    Bryce, Alan H.
    Ho, Thai H.
    Quevedo, Fernando J.
    Vora, Sujay A.
    CLINICAL GENITOURINARY CANCER, 2017, 15 (06) : E969 - E975
  • [27] Impact of treatment delay in Radium-223 therapy of metastatic castration-resistant prostate cancer patients
    Marie Øbro Fosbøl
    Peter Meidahl Petersen
    Gedske Daugaard
    Søren Holm
    Andreas Kjaer
    Jann Mortensen
    Annals of Nuclear Medicine, 2018, 32 : 16 - 21
  • [28] Radionuclide Therapies in Prostate Cancer: Integrating Radium-223 in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
    Nilsson, Sten
    CURRENT ONCOLOGY REPORTS, 2016, 18 (02) : 1 - 12
  • [29] The Timing of Radium-223 Therapy in Castration-Resistant Prostate Cancer
    Sartor, Oliver
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (09) : 570 - 572
  • [30] Radionuclide Therapies in Prostate Cancer: Integrating Radium-223 in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
    Sten Nilsson
    Current Oncology Reports, 2016, 18
12345